View of Treatment Retention and Hemoglobin Response During Darbepoetin Alfa and Recombinant Human Erythropoietin Beta Therapy in Children With CKD-Related Anemia: A Secondary Analysis of a Randomized Trial | The Planet

← Treatment Retention and Hemoglobin Response During Darbepoetin Alfa and Recombinant Human Erythropoietin Beta Therapy in Children With CKD-Related Anemia: A Secondary Analysis of a Randomized Trial